INHIBITORS OF INFLUENZA VIRUSES REPLICATION

Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a c...

Full description

Saved in:
Bibliographic Details
Main Authors JACOBS, Dylan H, WANG, Tiansheng, WANNAMAKER, Woods M, LEDFORD, Brian, COURT, John J, KENNEDY, Joseph M, LIN, Chao, GERMANN, Ursula A, SALITURO, Francesco G, CLARK, Michael P, BANDARAGE, Upul K, BETHIEL, Randy S, DUFFY, John. P, GAO, Huai, MALTAIS, Francois, JONES, Steven, KWONG, Ann Dak-Yee, GU, Wenxin, PEROLA, Emanuele, FARMER, Luc, BYRN, Randal, DENG, Hongbo, ZHOU, Yi, CHARIFSON, Paul, JIANG, Min, LEDEBOER, Mark W, DRUTU, Ioana
Format Patent
LanguageEnglish
French
German
Published 01.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula ( I ): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula ( IA ) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( IA ) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Bibliography:Application Number: EP20180177481